Disentangling the unique impacts of aging and reproductive aging through menopause may identify novel features of the pathogenesis of HIV that will inform strategies to manage longterm complications and achieve an HIV cure. Early data indicate that menopause and declining levels of estradiol are associated with increased inflammation and changes in HIV viral dynamics. Further work is needed to define the mechanisms of estradiol impacts on both HIV and the immune system.
CROI Conference
